Jan-Piet WIJGERGANGS;Merck Sharp & Dohme B.V.;Jocominus Antonius Maria ZWINKELS;Albert Falivene ALDEA
发明人:
Jan-Piet Wijgergangs,Jocominus Antonius Maria Zwinkels,Albert Falivene Aldea
申请号：
US15039262
公开号：
US20170157094A1
申请日:
2014.11.24
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The invention is a pharmaceutical tablet formulation comprising between about 12.5 mg and 100 mg losartan potassium, between about 6.25 mg and about 50 mg chlorthalidone, and sodium bicarbonate in an amount between about 1.0% and about 10.0% by weight.
